Predicting severe autoimmune encephalitis risk
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at people with a recent diagnosis of autoimmune encephalitis, a condition where the immune system mistakenly attacks the brain, to try to predict who might get severely ill. If you join, your health information and test results will be used to build a tool that may help doctors identify high-risk patients earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 80 years old
- You have been diagnosed with autoimmune encephalitis and have a known antibody in your spinal fluid
- Your diagnosis was made within the last 3 months
- You are willing to have a spinal tap (lumbar puncture) if not already done
- You have received or will receive immunotherapy (like steroids or IVIG)
- You were mostly independent before your illness (not needing constant care)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study follows patients with autoimmune encephalitis (brain inflammation caused by the immune system) to see how treatments affect them in the medium term. It may help doctors learn which treatments work best for people with this condition.
This trial tests a medicine called efgartigimod to treat autoimmune encephalitis (AIE)—a rare condition where the immune system attacks the brain. The study enrolls children 12+ and adults to see if this drug can reduce symptoms and help recovery.
This trial uses a special PET scan (with a tracer called [18F]-DPA-714) to see if it can measure inflammation in the brain caused by autoimmune encephalitis. The goal is to see if this scan can help doctors diagnose and monitor the condition more accurately.
Hear when a new Severe Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.